Butterfly Network, Inc. BFLY

Company Overview

Butterfly Network, Inc. is a U.S.-based digital health and medical imaging company focused on handheld ultrasound technology and software-enabled diagnostic imaging. The company operates primarily in the medical device and healthcare technology industries, developing portable ultrasound systems that integrate semiconductor-based imaging technology with mobile software platforms. Its core offering is the Butterfly iQ product line, which uses a proprietary ultrasound-on-chip architecture intended to replace traditional piezoelectric transducers with a single silicon chip capable of supporting multiple imaging modalities. Revenue is generated through hardware sales, software subscriptions, enterprise licensing, and cloud-based workflow and education services.

The company serves hospitals, health systems, physicians, nurses, emergency responders, educational institutions, and global health organizations. Butterfly has positioned itself as a lower-cost and more portable alternative to conventional cart-based ultrasound systems, emphasizing accessibility, telehealth integration, and point-of-care imaging. Founded in 2011 by Jonathan Rothberg, the company evolved from semiconductor and genomics innovation initiatives into a digital imaging platform provider. Butterfly became publicly traded in 2021 through a merger with a special purpose acquisition company.

Business Operations

Butterfly generates revenue through a combination of imaging devices, recurring software subscriptions, and enterprise solutions. Its primary operating platform includes the Butterfly iQ+, Butterfly iQ3, cloud-based imaging management software, tele-guidance capabilities, and educational applications. The company’s technology stack combines semiconductor imaging hardware, artificial intelligence-enabled workflow support, cloud connectivity, and mobile application infrastructure. Butterfly’s software ecosystem supports image storage, collaboration, clinical workflow integration, and remote care applications.

Operations are concentrated in the United States, though the company also markets products internationally across parts of Europe, Asia-Pacific, the Middle East, Africa, and Latin America through direct sales and distribution relationships. Butterfly has developed partnerships with healthcare systems, academic medical centers, and digital health organizations to support adoption of point-of-care ultrasound. The company also collaborates with medical education institutions and telemedicine providers to expand training and remote diagnostic capabilities.

Strategic Position & Investments

Butterfly’s strategic direction centers on expanding adoption of portable ultrasound technology and integrating artificial intelligence into imaging workflows. The company has invested in software-driven clinical decision support, automation tools, and enterprise connectivity solutions designed to improve usability for non-specialist clinicians. Management has emphasized recurring software revenue growth alongside hardware adoption as part of its long-term operating model. The company has also pursued integration opportunities with electronic medical record systems and telehealth platforms.

Butterfly has invested in research and development focused on semiconductor imaging technology, AI-assisted image acquisition, and cloud-enabled diagnostics. Its strategic positioning is based on scalability, portability, and lower manufacturing complexity relative to traditional ultrasound systems. The company operates in a competitive market that includes major imaging manufacturers and emerging digital health firms. Public filings and investor materials indicate continued focus on expanding enterprise accounts, increasing software utilization, and broadening international regulatory clearances.

Geographic Footprint

Butterfly Network, Inc. is headquartered in Burlington, Massachusetts, and maintains a primary operational focus in the United States. The company markets and distributes products across multiple international regions, including Europe, Asia-Pacific, Latin America, the Middle East, and parts of Africa. Its products have received regulatory clearances in numerous jurisdictions, supporting broader global commercialization efforts.

International operations are supported through a mix of direct commercial activity and distributor partnerships. Butterfly’s global strategy has included expanding point-of-care ultrasound access in underserved and remote healthcare environments, as well as supporting medical education initiatives internationally. The company’s cloud-based software infrastructure enables cross-border imaging collaboration and remote guidance capabilities for healthcare providers operating in diverse clinical settings.

Leadership & Governance

Butterfly was founded by Jonathan Rothberg, an entrepreneur known for biotechnology and semiconductor innovation ventures. The company’s leadership strategy has emphasized democratizing medical imaging through portable, software-enabled ultrasound systems and expanding access to diagnostic tools outside traditional radiology environments. Public company governance is overseen by a board of directors and executive leadership team with backgrounds in healthcare technology, medical devices, software, and finance.

Key executives include:

• Joseph DeVivo – President, Chief Executive Officer, and Chairman
• Heather Getz – Chief Financial Officer
• Darius Shahida – Chief Strategy and Business Development Officer
• Todd Fruchterman, MD – Former President and Chief Executive Officer
• Jonathan Rothberg – Founder and Director

Leadership communications and public filings indicate a strategic focus on operational efficiency, enterprise adoption, software monetization, and continued innovation in AI-enabled imaging technologies.